4
Changes in Ownership
Eloxx Pharmaceuticals, Inc. Filed Acc 0001144204-13-030378
Options or other derivatives
- Director acquired 273,256 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Waksal Harlan · Director
Table II: Derivative
1 line| Date | Transaction | Shares | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| 2013-05-17 | Grant or award : show line 1 in the form Common Stock Option | +273,256 | $0.04 | 2023-05-17 | 273,256 | 2,716,572 | D |
Loading xslF345X03/form459801_20130520115056-.xml…